Published in AIDS Weekly, July 28th, 2003
This is the first HVTN trial to be conducted simultaneously in the U.S. and abroad, and it signifies a dedication to transcending borders in the fight against HIV. This vaccine has never been tested in humans.
"Scientists want to know more about this candidate vaccine because it seems to have the ability to make the immune system respond in ways that could help the body fight HIV," said Geoffrey Gorse, MD, from St....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.